香港股市 已收市

Eli Lilly and Company (LLY)

NYSE - NYSE 延遲價格。貨幣為 USD。
加入追蹤清單
807.43-1.02 (-0.13%)
收市:04:00PM EDT
808.30 +0.87 (+0.11%)
收市後: 07:59PM EDT

Eli Lilly and Company

Lilly Corporate Center
Indianapolis, IN 46285
United States
317 276 2000
https://www.lilly.com

版塊Healthcare
行業Drug Manufacturers—General
全職員工43,000

高階主管

名稱頭銜支付行使價出生年份
Mr. David A. RicksChairman, CEO & President6.29M1968
Ms. Anat AshkenaziExecutive VP & CFO2.96M1973
Dr. Daniel M. Skovronsky M.D., Ph.D.EVP, Chief Scientific Officer and President of Lilly Research Laboratories & Lilly immunology3.82M1974
Ms. Anat Hakim J.D.Executive VP, General Counsel & Secretary2.81M1969
Mr. Jacob S. Van NaardenExecutive VP & President of Loxo2.38M1985
Mr. Donald A. ZakrowskiSenior VP of Finance & Chief Accounting Officer
Mr. Diogo RauEVP & Chief Information and Digital Officer1.06M1975
Mr. Alonzo WeemsEVP of Enterprise Risk Management and Chief Ethics & Compliance Officer1971
Mr. Eric DozierExecutive Vice President of Human Resources & Diversity1968
Mr. Jeffrey N. SimmonsSenior VP & President of Elanco Animal Health1.73M1967
截止 2023年12月31日為止計算的金額,現金賠償則計算至上一個財政年度末止。薪資是指薪俸、獎金等。已行使價是指財政年度期間已行使的期權價值。貨幣為 USD。

描述

Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. The company offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; Jardiance, Mounjaro, and Trulicity for type 2 diabetes; and Zepbound for obesity. It also provides oncology products, including Alimta, Cyramza, Erbitux, Jaypirca, Retevmo, Tyvyt, and Verzenio. In addition, the company offers Olumiant for rheumatoid arthritis, atopic dermatitis, severe alopecia areata, and COVID-19; Taltz for plaque psoriasis, psoriatic arthritis, ankylosing spondylitis, and non-radiographic axial spondylarthritis; Omvoh for ulcerative colitis; Cymbalta for depressive disorder, diabetic peripheral neuropathic pain, generalized anxiety disorder, fibromyalgia, and chronic musculoskeletal pain; Ebglyss for severe atopic dermatitis; and Emgality for migraine prevention and episodic cluster headache. Further, it provides Cialis for erectile dysfunction and benign prostatic hyperplasia; and Forteo for osteoporosis. It has collaborations with Incyte Corporation; Boehringer Ingelheim Pharmaceuticals, Inc.; F. Hoffmann-La Roche Ltd and Genentech, Inc.; Biologics, Inc., AbCellera Biologics Inc.; and Chugai Pharmaceutical Co., Ltd. The company was founded in 1876 and is headquartered in Indianapolis, Indiana.

公司管治

截至 2024年5月1日 止,Eli Lilly and Company 的 ISS 管治質素評分為 5。 Pillar 分數正在審核中:3;董事會:4;股東權利:9;現金賠償:1。

企業管治評分的資料提供: Institutional Shareholder Services (ISS). 評分將以 1 至 10 分顯示 (與指數或地區相關)。1 分表示較低的管治風險,而 10 分表示較高的管治風險。